Literature DB >> 2944967

Different regulation of the L3T4-T cell subset by B cells in different mouse strains bearing the H-2k haplotype.

V Brinkmann, S D Sharma, J S Remington.   

Abstract

Splenic L3T4-T cells from Toxoplasma gondii-infected CBA/J (H-2k, Igh 1a) but not C3H/He (H-2k, Igh 1j) mice responded with marked antigen-specific proliferation and interleukin 2 (IL 2) production, as well as concanavalin A-induced proliferation. The proliferative response of C3H/He spleen cells could be restored in part in vitro by addition of exogenous recombinant IL 2. The observed unresponsiveness of C3H/He spleen cells was due to the release of IL 2-inhibiting factors. These factors, present in culture supernatants from antigen restimulated C3H/He spleen cells, blocked the growth of an IL 2-dependent T cell line in the presence of optimal concentration of IL 2. During the early stages of infection, C3H/He splenic macrophages lacked the capacity to present antigen. In addition a nonspecific B cell-mediated suppression of T cell proliferation was observed. In later stages of infection macrophages displayed normal antigen-presenting function in comparison with macrophages of normal uninfected mice. At this stage of infection nonspecific, minor histocompatibility restricted B cell suppression was observed. These results suggest a possible role of B cells in regulation of T cell immunity to T. gondii.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.

Authors:  Y Suzuki; M A Orellana; S Y Wong; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

3.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon.

Authors:  Y Suzuki; F K Conley; J S Remington
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

5.  A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.

Authors:  Y Suzuki; K Joh; M A Orellana; F K Conley; J S Remington
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

6.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

7.  Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection.

Authors:  Ahmed Abou-Bacar; Alexander W Pfaff; Sophie Georges; Valérie Letscher-Bru; Denis Filisetti; Odile Villard; Elisabeth Antoni; Jean-Paul Klein; Ermanno Candolfi
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Spinal Cord Lesions in Congenital Toxoplasmosis Demonstrated with Neuroimaging, Including Their Successful Treatment in an Adult.

Authors:  Delilah Burrowes; Kenneth Boyer; Charles N Swisher; A Gwendolyn Noble; Mari Sautter; Peter Heydemann; Peter Rabiah; Daniel Lee; Rima McLeod
Journal:  J Neuroparasitology       Date:  2012-03

9.  Studies on the role of interleukin-12 in acute murine toxoplasmosis.

Authors:  C A Hunter; E Candolfi; C Subauste; V Van Cleave; J S Remington
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.

Authors:  F G Araujo; T Slifer
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.